While GLP-1 companies continue to accelerate, Weightwatchers (WW) leaves the ladder.
The weight loss program based on the point system filed a bankruptcy on May 6, its premature value dropped 52% on Wednesday morning.
An increasing debt burden forced the company to reduce operations, but current members have been assured that they would not be affected by the file. A reorganization plan is expected within 40 days, according to a statement released on Tuesday.
“While the conversation around weight moves to long -term health, our commitment to provide the most reliable solutions, supported by science and holistic – based on community support and sustainable results – has never been stronger or more important,” said Tara Comonte, general manager of WW.
Comonte suggested that the deposit was supported by lenders, who are determined to help the company lose its debt of $ 1.15 billion, to call on new customers and to innovate in the rapidly evolving weight management landscape – a space that is currently overwhelmed with competitive GLP -1 solutions.
Weightwatchers had trouble maintaining subscriptions while people turn to popular drugs like Ozempic, Mounjaro and Wegovy.
Originally used to treat diabetes, GLP-1 have become an attractive option for those looking to remove hunger and lose books quickly.
The company found a certain relief after adding GLP-1 Obesity Treatment in 2023, but did not move away from the more traditional approach to weight loss, focusing on food intake and behavioral changes. During Tuesday’s call, Comonte recognized the development of the use of GLP-1, but added that it was “a drug, not a miracle”.
According to a recent Kaiser Family Foundation survey, around 6% of American adults are currently taking GLP-1 for weight loss, and the effects are impressive. A study in 2022 revealed that people who received weekly semaglutide injections lost an average of around 15 pounds after three months.
Over the past two years, some insurance providers have announced that they would no longer offer coverage for weight loss drugs like Ozempic. In response, some have started to turn to TV companies such as RO, G -PLANS Direct and Remedy Meds – which all offer virtual prescriptions for various weight loss drugs, as well as other health services.
This is a difficult period to compete with new weight loss drugs; Different payment plans are available, the treatments are more accessible to people without insurance and television companies offer easier tracks towards obtaining a prescription. However, the GLP-1 landscape can be difficult to sail.
Here is the meager of telehantional companies that deserves to be considered.
This article was written by Miska Salemann, writer / journalist of the New York Post. As a member of Gen Z health, Miska is looking for experts to weigh on the advantages, safety and conceptions of trendy and proven fitness equipment, training clothes, food supplements and more. Taking things in hand, Metka intrepidly tests well-being products, ranging from the mixture of longevity of the plan of the plan of Bryan Johnson to elliptical gym machines at home at the favorite training platform of Jennifer Aniston-often with her adorable one-year-old daughter by her side. Before joining the post, Miska covered the lifestyle and consumption subjects for the US Sun and the Cannon Beach Gazette.
